Nearly a year after the World Health Organization (WHO) first declared the novel coronavirus a public health emergency, the agency released new clinical advice for both home and hospitalized treatments for COVID-19 patients.
The agency announced plans to conduct a study called so-called “long-kovid” or otherwise “covaged long-healers”, which continue to suffer from symptoms even after the infection is gone.
“Understanding this condition is one of WHO’s priority areas of work,” the agency said in a news release Tuesday. “In February 2021, WHO will conduct a series of consultations to reach consensus on the details of the condition and its subtypes, and case definitions. Scientific understanding will inform the name of the condition. The consultation covers a wide range of stakeholders Hoagie. Including patient groups. “
US asks for assistance in coronavirus residence: FAUCI
Meanwhile, for current patients who do not require hospitalization, WHO is recommending the use of pulse oximetry to measure oxygen levels in the blood. Over-the-counter products should be “coordinated with other aspects of home care, such as patents and education for the care provider and regular follow-up of the patient.”
For those requiring hospitalization, the agency recommends that health care providers consider using low-dose anticoagulants to prevent blood clots, as well as patients who are exposed to oxygen. Non-invasive supplements receive oxygen on their stomachs to increase flow.
Click here for complete coronary coverage
The agency noted that the guideline is “a living document, updated regularly as more data becomes available.” The update comes the same day the WHO announced that it was working with Modern to approve its COVID-19 shot for emergency use indexing.